moxonidine has been researched along with Goldblatt Syndrome in 2 studies
moxonidine: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"Moxonidine is a second-generation, centrally acting antihypertensive drug with a distinctive mode of action." | 2.39 | Pharmacology of moxonidine, an I1-imidazoline receptor agonist. ( Ernsberger, P; Haxhiu, MA; Kaan, EC; Papp, JG; Ziegler, D, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, P | 1 |
Penner, SB | 1 |
Smyth, DD | 1 |
Ziegler, D | 1 |
Haxhiu, MA | 1 |
Kaan, EC | 1 |
Papp, JG | 1 |
Ernsberger, P | 1 |
1 review available for moxonidine and Goldblatt Syndrome
Article | Year |
---|---|
Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cats; Dogs; Heart Rate; Hypertension | 1996 |
1 other study available for moxonidine and Goldblatt Syndrome
Article | Year |
---|---|
Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Hemodynamics; Hypertension, Renovascular; Imidazol | 1994 |